MaxCyte Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . MaxCyte
MXCT Stock  USD 3.52  0.14  4.14%   
MaxCyte financial statements provide useful quarterly and yearly information to potential MaxCyte investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MaxCyte financial statements helps investors assess MaxCyte's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MaxCyte's valuation are summarized below:
Gross Profit
39.2 M
Profit Margin
(0.78)
Market Capitalization
371.3 M
Enterprise Value Revenue
5.1133
Revenue
45.6 M
There are currently one hundred twenty fundamental ratios for MaxCyte that can be evaluated and compared over time across peers in the industry. All traders should check MaxCyte's last-minute fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

MaxCyte Total Revenue

21.86 Million

Check MaxCyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MaxCyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 138.6 K or Selling General Administrative of 31.6 M, as well as many indicators such as Price To Sales Ratio of 11.17, Dividend Yield of 0.0 or PTB Ratio of 2.2. MaxCyte financial statements analysis is a perfect complement when working with MaxCyte Valuation or Volatility modules.
  
Check out the analysis of MaxCyte Correlation against competitors.
For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.

MaxCyte Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets281.7 M268.3 M86.5 M
Slightly volatile
Short and Long Term Debt Total19.7 M18.7 M7.1 M
Slightly volatile
Other Current Liabilities10.2 M9.7 M3.8 M
Slightly volatile
Total Current Liabilities9.7 M17.9 M8.2 M
Slightly volatile
Property Plant And Equipment Net36.5 M34.8 M9 M
Slightly volatile
Current Deferred Revenue3.5 M5.1 M2.9 M
Slightly volatile
Accounts Payable705.9 K743 K1.7 M
Very volatile
Cash48.8 M46.5 M16.5 M
Slightly volatile
Non Current Assets Total82 M78.1 M15 M
Slightly volatile
Cash And Short Term Investments176.7 M168.3 M62.7 M
Slightly volatile
Net Receivables4.3 M5.8 M3.5 M
Slightly volatile
Common Stock Shares Outstanding66.8 M103.3 M58.8 M
Slightly volatile
Liabilities And Stockholders Equity281.7 M268.3 M86.5 M
Slightly volatile
Non Current Liabilities Total19.2 M18.3 M6.5 M
Slightly volatile
Inventory12.8 M12.2 M3.7 M
Slightly volatile
Other Current Assets4.1 M3.9 M1.5 M
Slightly volatile
Total Liabilities37.9 M36.1 M15.3 M
Slightly volatile
Total Current Assets199.7 M190.2 M71.6 M
Slightly volatile
Short Term Debt845.8 K1.5 M1.1 M
Slightly volatile
Common Stock542.8 K1 M431 K
Slightly volatile
Other Stockholder Equity222.4 M406.9 M145.2 M
Slightly volatile
Other Liabilities1.6 M1.5 M620.4 K
Slightly volatile
Net Tangible Assets306.7 M292.1 M88.8 M
Slightly volatile
Long Term Debt5.2 M5.7 M4.6 M
Slightly volatile
Common Stock Total Equity807.8 K1.2 M663.6 K
Slightly volatile
Net Invested Capital133.2 M232.2 M76.9 M
Slightly volatile
Property Plant And Equipment Gross47.3 M45 M9.6 M
Slightly volatile
Short and Long Term Debt680.7 K765.8 K833.9 K
Slightly volatile
Non Current Liabilities Other268.9 K283 K449.4 K
Pretty Stable
Net Working Capital118.2 M172.3 M68.9 M
Slightly volatile
Property Plant Equipment28.6 M27.3 M7.6 M
Slightly volatile
Short Term Investments103.8 M121.8 M46.4 M
Slightly volatile
Capital Stock905.1 K1 M663.2 K
Slightly volatile
Other Assets976.9 K930.4 K227.1 K
Slightly volatile
Capital Surpluse421.9 M449.4 M385.1 M
Slightly volatile

MaxCyte Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4.4 M4.2 M1.1 M
Slightly volatile
Interest Expense138.6 K145.9 K429.6 K
Pretty Stable
Selling General Administrative31.6 M30.1 M9.9 M
Slightly volatile
Selling And Marketing Expenses28.3 M27 M9 M
Slightly volatile
Total Revenue21.9 M41.3 M18 M
Slightly volatile
Gross Profit19.4 M36.5 M16 M
Slightly volatile
Other Operating Expenses94.1 M89.6 M32.6 M
Slightly volatile
Research Development12 M23.8 M9.8 M
Slightly volatile
Cost Of Revenue2.5 M4.7 M2.1 M
Slightly volatile
Total Operating Expenses89.1 M84.8 M30.4 M
Slightly volatile
Reconciled Depreciation4.2 M4 M1 M
Slightly volatile
Interest Income10 M9.5 M1.7 M
Slightly volatile

MaxCyte Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation14.7 M14 M3.7 M
Slightly volatile
Begin Period Cash Flow13.9 M11.1 M11.3 M
Slightly volatile
Depreciation4.4 M4.2 M1 M
Slightly volatile
Capital Expenditures2.9 M3.7 M2.3 M
Slightly volatile
End Period Cash Flow48.8 M46.5 M16.5 M
Slightly volatile
Change To Netincome14.4 M13.7 M4 M
Slightly volatile
Change To Liabilities751.1 K790.6 K1.1 M
Slightly volatile
Sale Purchase Of Stock255.6 K269 K192 M
Slightly volatile
Other Cashflows From Investing Activities3.7 K4.1 K4.5 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio11.1711.755569.2955
Slightly volatile
Days Sales Outstanding54.7451.079564.3735
Slightly volatile
Stock Based Compensation To Revenue0.360.33860.1026
Slightly volatile
Capex To Depreciation1.740.88711.8738
Slightly volatile
EV To Sales10.5311.083168.9812
Slightly volatile
Inventory Turnover0.370.38780.9444
Slightly volatile
Days Of Inventory On Hand988941472
Slightly volatile
Payables Turnover6.76.38222.9048
Slightly volatile
Sales General And Administrative To Revenue0.760.72830.4242
Slightly volatile
Research And Ddevelopement To Revenue0.420.57690.5036
Slightly volatile
Capex To Revenue0.06020.08960.0647
Slightly volatile
Cash Per Share1.711.62960.7059
Slightly volatile
Days Payables Outstanding54.3357.19414
Slightly volatile
Income Quality0.810.57180.7875
Slightly volatile
Current Ratio11.1810.65215.1978
Slightly volatile
Receivables Turnover6.347.14576.1174
Slightly volatile
Graham Number4.534.311.4876
Slightly volatile
Capex Per Share0.02350.03580.0251
Slightly volatile
Revenue Per Share0.240.39980.2715
Slightly volatile
Interest Debt Per Share0.00710.00750.0688
Slightly volatile
Debt To Assets0.00320.00330.3393
Slightly volatile
Operating Cycle1 K992536
Slightly volatile
Days Of Payables Outstanding54.3357.19414
Slightly volatile
Ebt Per Ebit1.250.78521.1314
Pretty Stable
Total Debt To Capitalization0.00360.00381.1762
Slightly volatile
Quick Ratio10.479.96724.8719
Slightly volatile
Net Income Per E B T1.10.971.0375
Slightly volatile
Cash Ratio2.732.60461.4909
Slightly volatile
Days Of Inventory Outstanding988941472
Slightly volatile
Days Of Sales Outstanding54.7451.079564.3735
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.011.17061.2072
Slightly volatile
Fixed Asset Turnover1.131.18818.0313
Slightly volatile
Debt Ratio0.00320.00330.3393
Slightly volatile
Price Sales Ratio11.1711.755569.2955
Slightly volatile
Asset Turnover0.150.15390.9564
Slightly volatile
Gross Profit Margin0.70.88510.8643
Very volatile

MaxCyte Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap720.2 M485.4 M856.1 M
Slightly volatile
Enterprise Value696.4 M457.6 M819.3 M
Slightly volatile

MaxCyte Fundamental Market Drivers

Cash And Short Term Investments168.3 M

MaxCyte Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MaxCyte Financial Statements

MaxCyte shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although MaxCyte investors may analyze each financial statement separately, they are all interrelated. The changes in MaxCyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on MaxCyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.1 M3.5 M
Total Revenue41.3 M21.9 M
Cost Of Revenue4.7 M2.5 M
Stock Based Compensation To Revenue 0.34  0.36 
Sales General And Administrative To Revenue 0.73  0.76 
Research And Ddevelopement To Revenue 0.58  0.42 
Capex To Revenue 0.09  0.06 
Revenue Per Share 0.40  0.24 
Ebit Per Revenue(1.17)(1.11)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY